AVI BioPharma Inc. is Today's Focus Stock on MicroStockProfit.com
August 24 2010 - 6:50AM
MicroStockProfit.com announces an investment report featuring AVI
BioPharma Inc. (Nasdaq:AVII). The report includes financial,
comparative and investment analyses, and industry information you
need to know to make an educated investment decision.
The full report is available at:
www.microstockprofit.com/lp/AVII
AVI BioPharma Inc. (AVII) is a biopharmaceutical company
specializing in the discovery and development of ribonucleic acid
(RNA)-based drugs targeting a range of diseases. The Company has
developed and optimized derivatives of its antisense chemistry
(phosphorodiamidate morpholino oligomers (PMOs)) that can be
designed to target disease mechanisms through mechanisms of action.
The applications of AVII's RNA technology platform include genetic
diseases (Duchenne muscular dystrophy (DMD)), infectious diseases
(Ebola and Marburg viruses), cardiovascular disease (restenosis)
and other early discovery targets. Several of its antiviral
programs, including Ebola, Marburg, Junin and Dengue, have been or
are funded by the United States government, and other governmental
and non-governmental funding. On March 20, 2008, the Company
acquired Ercole Biotechnology Inc.
Message Board Search for AVII:
http://www.boardcentral.com/boards/AVII
In the report, the analyst notes:
"For the second quarter of 2010 AVII reported an operating loss
of $7.7 million compared with an operating loss of $5.1 million in
the second quarter of 2009. The increase in the operating loss is
the result of a $2.6 million one-time charge for severance and
stock compensation costs related to the April 2010 departure of
AVII's former chief executive off.
"AVII recently announced the publication online in Nature
Medicine of new preclinical data demonstrating that AVI-6002 and
AVI-6003, the respective lead therapeutic candidates against Ebola
and Marburg viruses, both employing AVII's advanced PMOplus(TM)
chemistry, provide post exposure efficacy in non-human
primates."
To read the entire report visit:
www.microstockprofit.com/lp/AVII
See what investors are saying about AVII at
http://www.stockhideout.com
Get breaking news on AVII at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com
Brian Johnson
1-888-307-2850
info@microstockprofit.com
Avi Biopharma (NASDAQ:AVII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avi Biopharma (NASDAQ:AVII)
Historical Stock Chart
From Jul 2023 to Jul 2024